These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 9661602

  • 41. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea.
    Genazzani AD, Bersi C, Luisi S, Fruzzetti F, Malavasi B, Luisi M, Petraglia F, Genazzani AR.
    J Steroid Biochem Mol Biol; 2001 Sep; 78(3):247-52. PubMed ID: 11595505
    [Abstract] [Full Text] [Related]

  • 42. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid.
    Brigell DF, Fang VS, Rosenfield RL.
    J Clin Endocrinol Metab; 1992 May; 74(5):1036-9. PubMed ID: 1314844
    [Abstract] [Full Text] [Related]

  • 43. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
    White D, Leigh A, Wilson C, Donaldson A, Franks S.
    Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
    [Abstract] [Full Text] [Related]

  • 44. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
    Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR.
    Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
    [Abstract] [Full Text] [Related]

  • 45. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.
    Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER.
    J Rheumatol; 1998 Jul; 25(7):1374-81. PubMed ID: 9676772
    [Abstract] [Full Text] [Related]

  • 46. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.
    Wu XK, Zhou SY, Sallinen K, Pöllänen P, Erkkola R.
    Eur J Endocrinol; 2000 Sep; 143(3):383-8. PubMed ID: 11022181
    [Abstract] [Full Text] [Related]

  • 47. DHEA, DHEAS and PCOS.
    Goodarzi MO, Carmina E, Azziz R.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
    [Abstract] [Full Text] [Related]

  • 48. Adrenal androgen response to metyrapone, adrenocorticotropin, and corticotropin-releasing hormone stimulation in children with hypopituitarism.
    Pang SY, Legido A, Levine LS, Temeck JW, New MI.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):282-9. PubMed ID: 3036902
    [Abstract] [Full Text] [Related]

  • 49. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N, Taylor AE.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [Abstract] [Full Text] [Related]

  • 50. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 51. Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.
    Invitti C, De Martin M, Delitala G, Veldhuis JD, Cavagnini F.
    Metabolism; 1998 Feb; 47(2):143-8. PubMed ID: 9472960
    [Abstract] [Full Text] [Related]

  • 52. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R, Patton L, Pocognoli P, Cognigni GE, Gambineri A.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [Abstract] [Full Text] [Related]

  • 53. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M, Foppiani L, Minuto F.
    J Endocrinol Invest; 2002 Nov; 25(10 Suppl):19-23. PubMed ID: 12508908
    [Abstract] [Full Text] [Related]

  • 54. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [Abstract] [Full Text] [Related]

  • 55. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
    Sahin Y, Keleştimur F.
    Hum Reprod; 1997 May; 12(5):910-3. PubMed ID: 9194638
    [Abstract] [Full Text] [Related]

  • 56. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R, Ishai A, Shen-Or Z, Herer P.
    Neuro Endocrinol Lett; 2003 May; 24(3-4):249-54. PubMed ID: 14523365
    [Abstract] [Full Text] [Related]

  • 57. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [Abstract] [Full Text] [Related]

  • 58. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [Abstract] [Full Text] [Related]

  • 59. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
    De Leo V, la Marca A, Lanzetta D, Cariello PL, D'Antona D, Morgante G.
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
    [Abstract] [Full Text] [Related]

  • 60. Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time.
    Azziz R, Bradley E, Huth J, Boots LR, Parker CR, Zacur HA.
    J Clin Endocrinol Metab; 1990 May; 70(5):1273-9. PubMed ID: 2139878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.